Private Equity

A new partnership in Pennsylvania highlights the rise of 'doctor-led' support organizations, a model reshaping the business of specialized dental care.

A new Texas facility is using high-energy flashes to turn electronic junk into gold, aiming to secure America's critical metal supply chain.

Sammons Financial Group names Sergi Turabelidze its new CIO, tasking him with overhauling its massive $135B portfolio using alternative asset expertise.

A leading Idaho dental group is up for sale, highlighting the growing trend of private equity investment and consolidation in local healthcare services.

Jimmy Hutcheson brings his media revival expertise from SPIN Magazine to the Playing For Change Foundation, aiming to boost its global youth arts programs.

Following a major investment, Trialbee appoints a seasoned leader to its board, signaling a push for dominance in AI-driven clinical trial recruitment.

Amid Europe's market comeback, DWS launches the XEML ETF, offering a targeted way for U.S. investors to tap into the continent's top 40 companies.

Private equity firm Astara Capital Partners hires a top talent chief, signaling a strategic shift from financial engineering to human-led operational growth.

PatientPoint founder Mike Collette joins Carefeed's board, signaling a major push to tackle senior living's operational crises with proven tech leadership.

A new Edmonton health centre embeds pharmacy services directly into patient care, aiming to fix a fragmented system and empower local pharmacists.

Easterly Asset Management's deal to absorb Olstein's funds marks a key industry consolidation, promising lower fees and a unified value investing powerhouse.

The private equity firm hires Laura Noisten to lead leveraged finance, a strategic move to fuel growth in the complex aerospace and defense tech sector.

PainTEQ's landmark deal, crowned 'Deal of the Year,' showcases a new model for medtech growth and its patient-first mission in pain management.

Risk Theory's first MGA acquisition of Roundhill Express signals a new buy-and-build era, targeting the high-stakes NYC specialty property market.

REPKON USA rebrands as Paligen, signaling a new era of domestic defense manufacturing fueled by a landmark TNT contract and strategic acquisitions.

After its Alzheimer's drug failed amidst controversy, Cassava Sciences rebrands as Filana Therapeutics, betting its future on a rare epilepsy disorder.

In a tough PE climate, Truelink Capital rapidly closes its second fund at its $2B hard cap, signaling strong investor belief in its operational strategy.

VLS Environmental Solutions expands its hazardous waste network by acquiring California-based IDR, a strategic move in a highly regulated market.

An Austin startup is launching an intelligence platform to help marketing leaders see a company's red flags before accepting a misaligned leadership role.

Praesidian Capital unites iconic model train maker Lionel with hobby giant Round 2, creating a new collectibles empire focused on innovation and growth.